type here...

CATEGORIES

Breaking Research

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Breakthrough Infections Dramatically Enhance COVID Immunity

Dr. Hesham A. Hassaballa -
I do not wish a breakthrough infection on anyone. If one does get a breakthrough, though, the silver lining is that the immunity after such infection is very, very robust.

Fighting Age-Related Macular Degeneration

Michael Hunter, MD -
A new study confirms supplements slow macular degeneration, an eye condition that can cause blindness.

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne -
Readers, including even experts, are falling for a hard sell job by venture capitalists who launder their funding of the study through a nonprofit foundation and seek not legalization

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories